Cardiol Therapeutics, Inc. (CRDL)
1.12
-0.03
(-2.61%)
USD |
NASDAQ |
Oct 23, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Market Cap : 129.79M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 129.79M |
| October 22, 2026 | 133.27M |
| October 21, 2026 | 135.59M |
| October 20, 2026 | 133.27M |
| October 19, 2026 | 127.47M |
| October 16, 2026 | 127.47M |
| October 15, 2026 | 133.27M |
| October 14, 2026 | 132.11M |
| October 13, 2026 | 139.06M |
| October 12, 2026 | 136.74M |
| October 09, 2026 | 142.54M |
| October 08, 2026 | 150.65M |
| October 07, 2026 | 152.97M |
| October 06, 2026 | 151.81M |
| October 05, 2026 | 152.97M |
| October 02, 2026 | 163.40M |
| October 01, 2026 | 180.78M |
| September 30, 2026 | 192.37M |
| September 29, 2026 | 195.85M |
| September 28, 2026 | 195.85M |
| September 25, 2026 | 198.16M |
| September 24, 2026 | 200.48M |
| September 23, 2026 | 205.12M |
| September 22, 2026 | 219.02M |
| September 21, 2026 | 215.55M |
| Date | Value |
|---|---|
| September 18, 2026 | 217.28M |
| September 17, 2026 | 215.55M |
| September 16, 2026 | 220.18M |
| September 15, 2026 | 214.39M |
| September 14, 2026 | 230.61M |
| September 11, 2026 | 231.19M |
| September 10, 2026 | 229.45M |
| September 09, 2026 | 264.80M |
| September 08, 2026 | 257.26M |
| September 04, 2026 | 254.95M |
| September 03, 2026 | 250.31M |
| September 02, 2026 | 251.47M |
| September 01, 2026 | 249.15M |
| August 31, 2026 | 228.87M |
| August 28, 2026 | 224.82M |
| August 27, 2026 | 238.72M |
| August 26, 2026 | 247.99M |
| August 25, 2026 | 231.77M |
| August 24, 2026 | 215.55M |
| August 21, 2026 | 215.55M |
| August 20, 2026 | 218.44M |
| August 19, 2026 | 227.13M |
| August 18, 2026 | 219.60M |
| August 17, 2026 | 208.59M |
| August 14, 2026 | 208.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.689M |
| NervGen Pharma Corp. | 152.17M |
| Milestone Pharmaceuticals, Inc. | 80.70M |
| Appili Therapeutics, Inc. | 0.9001M |
| Clearmind Medicine, Inc. | 12.59M |
Market Cap Related Metrics
| Price to Book Value | 7.663 |
| Price | 1.12 |
| Earnings Yield | -22.11% |